Chimeric exosomes-derived immunomodulator restoring lymph nodes microenvironment for sensitizing TNBC immunotherapy
Abstract Immunotherapy is a breakthrough in the treatment of triple-negative breast cancer (TNBC), although it is only effective in a portion of patients. Our clinical studies find that pathological elevated level of reactive oxygen species (ROS) and lipid homeostasis imbalance are closely associate...
Saved in:
| Main Authors: | Mengchi Sun, Yuxia Wu, Zhichao Chen, Boyan Zhang, Xiaoyang Liu, Peipei Ouyang, Ping Chen, Lujun Chen, Zhonggui He, Tao Han, Heran Li, Jin Sun, Shuang Cai, Qiuhua Luo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-08-01
|
| Series: | Nature Communications |
| Online Access: | https://doi.org/10.1038/s41467-025-62543-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Immunomodulation Potential of Exosomes in Tumor Microenvironment
by: Meng Wang, et al.
Published: (2021-01-01) -
Gut microbiota reshapes the TNBC immune microenvironment: Emerging immunotherapeutic strategies
by: Mingyao Huang, et al.
Published: (2025-05-01) -
PIBF1 expression and survival outcome in TNBC and Non-TNBC breast cancer patients with lymph node metastasis who undertaken chemotherapy
by: Eunju Shin, et al.
Published: (2025-08-01) -
A select inhibitor of MORC2 encapsulated by chimeric membranecoated DNA nanocage target alleviation TNBC progression
by: Xiaohan Su, et al.
Published: (2025-04-01) -
Transformable self-assembling peptide nanoplatforms with tumor microenvironment responsiveness for tumor stem cell suppression and immunomodulation
by: Chen Wei, et al.
Published: (2025-08-01)